Pregabalin Completed Phase 4 Trials for Anxiety-comorbidity to Schizophrenia / Schizophrenia Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01496690Pregablin for Anxiety-comorbidity in Patients With Schizophrenia